• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Basic Materials·BALAMINES.NS
Share

Balaji Amines Limited Stocks

₹ 2289.1Last Updated 17.07.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

₹ 820.79M

₹ 2289.1
Key Takeaways

Risk factor

Limited trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Balaji Amines Limited, an Indian company, specializes in the production and global distribution of methylamines, ethylamines, their associated derivatives, alongside a diverse portfolio of specialty chemicals and pharmaceutical excipients. The firm's business activities span three primary divisions: Amines & Speciality Chemicals, its Hotel operations, and CFL Lamp manufacturing. Within its chemical segment, Balaji Amines produces a wide range of amines, including monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl/diethyl amino ethanol. Its specialty chemicals encompass compounds like N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, and acetonitrile. Additionally, the company provides derivatives such as di-methyl acetamide, various amine hydrochlorides (di-methyl, tri-methyl, di-ethyl, tri-ethyl), di-methyl urea, and choline chloride. For the pharmaceutical industry, it supplies excipients like poly vinyl pyrrolidone. These chemical products cater to a broad array of sectors, including pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning, dye and textile, and water treatment industries. Beyond its chemical endeavors, the company also owns and manages Balaji Sarovar, a hotel property located in Solapur, Maharashtra, and is involved in the manufacturing and sale of CFL lamps. Balaji Amines maintains a significant international presence, exporting its goods to markets across the United States, Europe, China, Turkey, Korea, Malaysia, Kuwait, and other global regions. The company was founded in 1988 and is headquartered in Hyderabad, India.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EB

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of BALAMINES.NS is 2006 and suggests 12.4% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendat

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

19.07.2026 21:00

DeepSeek Is Preparing for Its IPO, Shein Has Reached an Agreement with the Regulator: Key Updates on IPOs by July 19

19.07.2026 15:01

The First Bubble in U.S. History: How Investors Went Wild—and What Does Elon Musk Have to Do With It?

18.07.2026 16:01

Small caps last week: Papa John's doubts, Perfect goes private, LLY-AtaiBeckley deal

18.07.2026 13:01

IBM's Worst Day, SK Hynix's Record Plunge, and the "Earnings Bubble" in AI

18.07.2026 03:31

Meta Is in Talks with Anthropic to Lease Data Centers for $10 Billion — The New York Times

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026